LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

COMMON STOCK | |

Last Closing

CAD 21.12

Change

-0.10 (-0.47)%

Market Cap

CAD 0.01B

Volume

8.84K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

-0.07 (-0.28%)

CAD 192.15B
TD-PFD:CA Toronto Dominion Bank Pref D

-0.15 (-0.63%)

CAD 161.10B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

-0.17 (-0.67%)

CAD 153.48B
TD-PFL:CA Toronto-Dominion Bank Pref Ser..

N/A

CAD 141.08B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

-0.09 (-0.36%)

CAD 140.97B
ENB-PFA:CA Enbridge Inc Pref 9

-0.03 (-0.16%)

CAD 112.66B
ENB-PFV:CA Enbridge Inc Pref 5

+0.09 (+0.41%)

CAD 110.07B
ENB-PFC:CA Enbridge Inc Pref 11

-0.07 (-0.39%)

CAD 106.90B
ENB-PFG:CA Enbridge Inc Pref 15

-0.12 (-0.70%)

CAD 101.50B
ENB-PFU:CA Enbridge Inc Pref L

+0.05 (+0.24%)

CAD 80.94B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.59% N/A N/A 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.59% N/A N/A 36% F
Trailing 12 Months  
Capital Gain -3.61% N/A N/A 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.61% N/A N/A 24% F
Trailing 5 Years  
Capital Gain 11.33% N/A N/A 51% F
Dividend Return 6.80% N/A N/A 32% F
Total Return 18.13% N/A N/A 48% F
Average Annual (5 Year Horizon)  
Capital Gain 1.74% N/A N/A 50% F
Dividend Return 2.90% N/A N/A 49% F
Total Return 1.17% N/A N/A 38% F
Risk Return Profile  
Volatility (Standard Deviation) 7.40% N/A N/A 78% C+
Risk Adjusted Return 39.23% N/A N/A 65% D
Market Capitalization 0.01B N/A N/A 9% A-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike